Syngene International
↗Bengaluru, India
Syngene International Limited is a leading global integrated contract research, development, and manufacturing organization (CRDMO). It provides a wide range of services across the drug discovery and development lifecycle, from early-stage target identification to commercial-scale manufacturing. The company serves diverse sectors including pharmaceuticals, biotechnology, nutrition, animal health, and specialty chemicals.
Syngene is known for its 'Dedicated Center' model, where it builds and operates long-term, exclusive R&D facilities for major global pharmaceutical companies. It operates over 2.5 million square feet of world-class R&D and manufacturing space across campuses in Bangalore, Hyderabad, and Mangalore, and has recently expanded its footprint into the United States.
CLASSIFICATION
SIZE & FINANCIALS
Employees:5001-10000
Revenue:$430M (FY25)
Founded:1993
Ownership:public
Status:operating
FUNDING
Stage:Public
Total Raised:$195M (Historical)
Investors:Biocon Limited (Parent), Silver Lake, Public Shareholders
STOCK
Exchange:NSE
Ticker:SYNGENE
Market Cap:$3.5B - $4.0B
PIPELINE
Stage:Commercial
Lead Drug Stage:Not applicable (Service Provider)
Modalities:Small molecule, mAb, ADC, Cell therapy, Gene therapy, Peptides, Oligonucleotides, PROTACs
Active Trials:150
Trial Phases:Phase 1: 60 | Phase 2: 50 | Phase 3: 30 | Phase 4: 10
FDA Approvals:5
EMA Approvals:3
CORPORATE STRUCTURE
Parent Company:Biocon Limited
Subsidiaries:Syngene USA Inc., Syngene Scientific Solutions Limited, Syngene Manufacturing Solutions Limited
Key Partnerships:Bristol Myers Squibb (BMS) - Strategic collaboration extended through 2035, Amgen - Dedicated R&D center, Baxter - Dedicated R&D center, Zoetis - Long-term manufacturing agreement, GSK - Discovery and development services, Merck KGaA - Research collaboration
COMPETITION
Position:Leader
Competitors:WuXi AppTec, Charles River Laboratories, Lonza, Catalent, Eurofins Scientific, Samsung Biologics
LEADERSHIP
Key Executives:
Peter Bains - MD & CEO
Deepak Jain - CFO
Kiran Mazumdar Shaw - Non-Executive Chairperson
Scientific Founders:Kiran Mazumdar Shaw
Board Members:Kiran Mazumdar Shaw, Peter Bains, Sibaji Biswas, Vinita Bali, Paul Blackburn, Vijay Kuchroo
LINKS
Disclaimer: IntuitionLabs.ai is not affiliated with, endorsed by, or associated with Syngene International. The information on this page was collected and compiled using AI agents from publicly available sources. While we strive for accuracy, this data may be incomplete, outdated, or contain errors. For official information, please visit the company's website directly. If you notice any inaccurate information, please contact us.